The Hepatitis C Virus Genotyping Detection Kit market refers to the industry that provides diagnostic kits for detecting and genotyping Hepatitis C Virus (HCV). As the Hepatitis C Virus Genotyping Detection Kit market size is expected to grow significantly, driven by increasing awareness and growth outlook, the market forecast indicates a promising future for industry expansion. The scope of this market encompasses various genotyping detection kits, including PCR-based, sequencing-based, and immunoassay-based kits, catering to diverse end-users such as hospitals, research institutions, and diagnostic laboratories. According to recent market research, the current Hepatitis C Virus Genotyping Detection Kit market size is approximately $1.4 billion. The market is anticipated to witness a CAGR of around 8%, driven by macro drivers such as increasing HCV prevalence, advancements in diagnostic technologies, and growing healthcare expenditure.